5VVU
Structural Investigations of the Substrate Specificity of Human O-GlcNAcase
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 21-ID-G |
Synchrotron site | APS |
Beamline | 21-ID-G |
Temperature [K] | 80 |
Detector technology | CCD |
Collection date | 2017-04-15 |
Detector | MARMOSAIC 300 mm CCD |
Wavelength(s) | 0.978 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 82.507, 96.060, 88.968 |
Unit cell angles | 90.00, 114.51, 90.00 |
Refinement procedure
Resolution | 50.000 - 2.700 |
R-factor | 0.21091 |
Rwork | 0.208 |
R-free | 0.27549 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 5un8 |
RMSD bond length | 0.012 |
RMSD bond angle | 1.592 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0131) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.010 | 2.750 |
High resolution limit [Å] | 2.700 | 2.700 |
Rpim | 0.043 | 0.410 |
Number of reflections | 34865 | 1705 |
<I/σ(I)> | 22 | 1.6 |
Completeness [%] | 99.8 | 97.3 |
Redundancy | 4.4 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | EVAPORATION | 293 | 0.024 M ammonium citrate tribasic (pH 7.0), 0.015 M MES monohydrate, 0.096 M potassium thiocyanate, 0.25 M Sodium acetate trihydrate, 0.037 M imidazole, 0.002 M zinc sulfate heptahydrate, 9.6 % w/v polyethylene glycol 3,350, 2.4 % w/v polyethylene glycol monomethyl ether 2,000, and 4% w/v polyethylene glycol monomethyl ether 550 |